Loading...


*  Ada Yonath - Wikipedia
... illuminated mechanisms of drug resistance and synergism, deciphered the structural basis for antibiotic selectivity and showed ... Yonath focuses on the mechanisms underlying protein biosynthesis, by ribosomal crystallography, a research line she pioneered ... how it plays a key role in clinical usefulness and therapeutic effectiveness, thus paving the way for structure-based drug ...
  https://en.wikipedia.org/wiki/Ada_Yonath
*  Cancers | Free Full-Text | The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy | HTML
Pak, B.J.; Chu, W.; Lu, S.J.; Kerbel, R.S.; Ben-David, Y. Lineage-specific mechanism of drug and radiation resistance in ... Goldie, J.H. Drug resistance in cancer: A perspective. Cancer Metastasis Rev. 2001, 20, 63-68. [Google Scholar] [PubMed] ... Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance ... Overexpression associated with drug and radiation resistance.. Wheeler, et al. [18]. Liu, et al. [180]. Liu, et al. [181]. ...
  https://www.mdpi.com/2072-6694/6/4/1953/htm
*  The Organic Chemistry Of Drug Design And Drug Action, Book by Richard B. Silverman (Hardcover) | chapters.indigo.ca
Buy the Hardcover Book The Organic Chemistry Of Drug Design And Drug Action by Richard B. Silverman at Indigo.ca, Canada's ... Drug Resistance and Drug Synergism 7.1. Drug Resistance 7.1.1. What is Drug Resistance? 7.1.2. Mechanisms of Drug Resistance ... Drug Synergism (Drug Combination) 7.2.1. What is Drug Synergism? 7.2.2. Mechanisms of Drug Synergism 7.2.2.1. Inhibition of a ... Chapter 7 (Drug Resistance and Drug Synergism): This new chapter includes topics taken from two chapters in the previous ...
  https://www.chapters.indigo.ca/en-ca/books/the-organic-chemistry-of-drug/9780123820303-item.html
*  Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action
... it can be used to overcome drug resistance by combining with other chemotherapeutic drugs [240]. We have found synergism at ... In combination with chemotherapy, it is recommended for use in HCT-15 cell lines, being aimed to reduce drug resistance by ... with clinically used chemotherapeutic drugs to reduce dose related side effects of chemotherapy and overcoming drug resistance ... Mechanism of action has been linked to the inhibition of growth and activation of the epidermal growth factor receptor and ...
  https://www.hindawi.com/journals/bmri/2018/4154185/
*  Antileukemic Activity and Mechanism of Drug Resistance to the Marine Salinispora tropica Proteasome Inhibitor Salinosporamide A...
Consistently, combination indices indicated synergism for all four combinations that achieved more than 50% cell growth ... In fact, multiple mechanisms can be accountable in contributing to either intrinsic or acquired resistance, e.g., drug efflux ... Antileukemic Activity and Mechanism of Drug Resistance to the Marine Salinispora tropica Proteasome Inhibitor Salinosporamide A ... Antileukemic Activity and Mechanism of Drug Resistance to the Marine Salinispora tropica Proteasome Inhibitor Salinosporamide A ...
  http://molpharm.aspetjournals.org/content/86/1/12
*  Never Heard of Her - Ada E. Yonath - But She Changed the World - All By Herself | One Person Changed The World
... illuminated mechanisms of drug resistance and synergism, deciphered the structural basis for antibiotic selectivity and showed ... Simply - this understand helps persons and companies develop effective drugs.. Yonath elucidated the modes of action of over ... Yonath focuses on the mechanisms underlying protein biosynthesis, by ribosomal crystallography, a research line she pioneered ... how it plays a key role in clinical usefulness and therapeutic effectiveness, thus paving the way for structure-based drug ...
  https://onepersonchangedtheworld.wordpress.com/2014/01/16/never-heard-of-her-ada-e-yonath-but-she-changed-the-world-all-by-herself/
*  The Organic Chemistry of Drug Design an... | WHSmith Books
Buy The Organic Chemistry of Drug Design and Drug Action (3rd edition) by Richard B. Silverman From WHSmith today! FREE ... Drug Resistance and Drug Synergism 7.1. Drug Resistance 7.1.1. What is Drug Resistance? 7.1.2. Mechanisms of Drug Resistance ... Drug Synergism (Drug Combination) 7.2.1. What is Drug Synergism? 7.2.2. Mechanisms of Drug Synergism 7.2.2.1. Inhibition of a ... Toxicity of DNA-Interactive Drugs 6.1.3. Combination Chemotherapy 6.1.4. Drug Interactions 6.1.5. Drug Resistance 6.2. DNA ...
  https://www.whsmith.co.uk/products/the-organic-chemistry-of-drug-design-and-drug-action-3rd-edition/9780123820303
*  Plus it
Synergism between two drugs could provide a key advance to enhance effectiveness, decrease resistance and reduce toxicities. ... Abstract P6-17-04: Mechanisms of drug sensitization by DHA on doxorubicin-resistant human breast adenocarcinoma ... range 0.01-0.67 suggesting strong synergism. A separately performed Live Dead Cell Assay also confirmed synergism (mean CI of ... Treatment: New Drugs and Treatment Strategies. *. Abstract P6-12-14: Proteasome inhibitors prevent bi-directional HER2/estrogen ...
  http://cancerres.aacrjournals.org/content/76/4_Supplement/P6-13-16
*  Rohde - Bio
B. Mechanisms of Resistance include the following: development of an enzyme that destroys or inactivates the drug; alteration ... 2. Two antibiotics may be administered simultaneously so they can exert an additive effect (synergism). Ex. penicillin is often ... C. First Line, Second-Line, and Third-Line Drugs as a strain of bacteria acquires resistance to a drug, another drug must be ... D. Cross-resistance resistance to 2 or more similar antimicrobials via a common mechanism. Ex. Penicillin contains a structure ...
  http://www.austincc.edu/rohde/CHP12a.htm
*  The Physiologic Basis of Diuretic Synergism: Its Role in Treating Diuretic Resistance | Annals of Internal Medicine | American...
When diuretic resistance is present, using a second diuretic drug that acts in a different nephron segment is often effective. ... On the basis of an understanding of the mechanisms of diuretic adaptation and resistance, treatment regimens can be designed to ... The Physiologic Basis of Diuretic Synergism: Its Role in Treating Diuretic Resistance. Ann Intern Med. 1991;114:886-894. doi: ... The Physiologic Basis of Diuretic Synergism: Its Role in Treating Diuretic Resistance David H. Ellison, MD ...
  http://annals.org/aim/article-abstract/704671/physiologic-basis-diuretic-synergism-its-role-treating-diuretic-resistance
*  Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt
Drug synergism, addition, and antagonism were defined by CI values of ,1.0, 1.0, and ,1.0, respectively. For each drug, at ... The molecular mechanisms behind the synergism between erlotinib and gemcitabine most likely involved the decreased p-Akt ... In the A-431 parental cells, the drug combination resulted in a CI value of 0.69 at ED50, indicating synergism between ... However, resistance to EGFR tyrosine kinase inhibitors presents a therapeutic challenge; some tumors seem to resist these drugs ...
  http://jcancer.org/v02p0435.htm
*  Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3...
Cell Survival/drug effects. *Cell Survival/physiology. *Drug Resistance, Neoplasm. *Drug Synergism ... Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/ ... These findings indicate that hepatoma cells overcome IGF-1R inhibition through HER3 activation in an EGFR-dependent mechanism, ... and that HER3 represents a critical mediator in acquired resistance to anti-IGF-1R therapy. These results provide a strong ...
  https://www.ncbi.nlm.nih.gov/pubmed/19706799
*  New antimicrobial combinations: substituted chalcones- oxacillin against methicillin resistant Staphylococcus aureus
In general, bacteria have the genetic ability to transmit and acquire resistance to drugs, which are utilized as therapeutic ... The aim of the present work was to investigate in vitro synergism between several chalcones substituted in combination with ... The results were satisfactory for all assayed combinations and in accordance with the mechanism of bacteriostatic inhibition ... Further investigations are needed to characterize the interaction mechanism with antibiotics. Thus, chalcones - oxacillin ...
  http://www.scielo.br/scielo.php?script=sci_abstract&pid=S1517-83822011000200010&lng=en&nrm=iso&tlng=en
*  From plants to pharmacy shelf: natural products revival | SpringerLink
... drugs and leads for the treatment of infectious disease that are rapidly developing resistance to previously effective drugs. ... Mikulasova M, Chovanova R, Vaverkova S (2016) Synergism between antibiotics and plant extracts or essential oils with efflux ... and pure compounds against Leishmania parasites along with the data on structure-activity relationships and possible mechanisms ... Cragg GM, Grothaus PG, Newman DJ (2014) New horizons for old drugs and drug leads. J Nat Prod 77:703-723CrossRefPubMedGoogle ...
  https://link.springer.com/article/10.1007/s11101-016-9465-1
*  Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial...
Despite the encouraging efficacy in clinical, the acquired resistance... ... Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug ... Mizuuchi H, Suda K, Murakami I, Sakai K, Sato K et al (2016) Oncogene swap as a novel mechanism of acquired resistance to ... Loss of EGFR could be proposed as a potential acquired resistance mechanism of AZD9291 in EGFR-mutant NSCLC cells with an EMT ...
  https://rd.springer.com/article/10.1007%2Fs00432-018-2668-7
*  Plus it
... chemotherapeutic drugs deserves special attention because it offers new insights into the mechanism of chemotherapy resistance ... To test for synergism between decorin and chemotherapeutic drugs, carboplatin (100 μg/ml; Bristol Laboratories, Princeton, NJ) ... Teicher BA, Maehara Y, Kakeji Y, et al Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor ... Teicher BA, Ikebe M, Ara G, Keyes SR, Herbst RS Transforming growth factor-beta 1 overexpression produces drug resistance in ...
  http://clincancerres.aacrjournals.org/content/10/14/4776
*  Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule...
... thus suggesting a potential mechanism for this combination. Targeting PI3K may enhance the efficacy of anti-microtubule drugs ... The aim of this study was to evaluate if PI3K or AKT inhibition can prevent resistance to chemotherapy and potentiate its ... treatment of ipatasertib and taselisib plus vinorelbine or paclitaxel or eribulin was evaluated A significant synergism of ... AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.. ...
  https://www.sigmaaldrich.com/catalog/papers/29100327
*  JCI - Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin
Synergism is defined by P , 0.05 in 2-way ANOVA test for synergism in panels A and B. The activation mechanisms, including ... Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. ... While many studies have demonstrated the regulatory mechanisms of WT mTORC1 (2, 4-10, 19, 60-63), the activating mechanism of ... The statistics of synergism. J Mol Cell Cardiol. 1998;30(4):723-731.. View this article via: PubMed CrossRef Google Scholar ...
  https://www.jci.org/articles/view/86120
*  Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
... mechanisms of action and potential for resistance," Drug Resistance Updates, vol. 7, no. 4-5, pp. 233-244, 2004. View at ... synergism). ... A leading cause of drug resistance is the drug efflux generated ... which in turn may be involved in drug response, drug interactions, mechanisms of resistance, and collateral effects in normal ... resistance between anticancer agents and artemisinins might be based on different mechanisms of drug action and/or resistance. ...
  https://www.hindawi.com/journals/bmri/2012/247597/
*  Jantoven (Warfarin Sodium Tablets): Side Effects, Interactions, Warning, Dosage & Uses
... drug interactions, warnings, patient labeling, reviews, and related medications. ... Pharmacodynamic mechanisms for drug interactions with JANTOVEN are synergism (impaired hemostasis, reduced clotting factor ... hereditary resistance). Pharmacokinetic mechanisms for drug interactions with JANTOVEN are mainly enzyme induction, enzyme ... Table 3: Drugs that Can Increase the Risk Of Bleeding. Drug Class. Specific Drugs. ...
  https://www.rxlist.com/jantoven-drug.htm
*  Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. ecancermedicalscience - The open...
48. Mulcahy Levy JM et al (2017) Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain ... Synergism with approved anti-cancer drugs. Existing anti-cancer therapies often induce pro-survival autophagy in cancer cells, ... Both drugs can be administered as monotherapy or as adjuvant agents to increase the efficacy and to limit drug resistance of ... 77. Kuznik A et al (2011) Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines The Journal of ...
  http://ecancer.org/journal/11/full/781-repurposing-drugs-in-oncology-redo-chloroquine-and-hydroxychloroquine-as-anti-cancer-agents.php
*  Download [PDF] Principles Of Chemistry A Molecular Approach 3rd Edition Free - Usakochan PDF
Drug Resistance and Drug Synergism): This new chapter includes topics taken from two chapters in the previous edition, with ... which allows reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new ... The Organic Chemistry of Drug Design and Drug Action, Third Edition, represents a unique approach to medicinal chemistry based ... Drug-receptor interactions, cation-π and halogen bonding; atropisomers; case history of the insomnia drug suvorexant Chapter 4 ...
  http://usakochan.net/download/principles-of-chemistry-a-molecular-approach-3rd-edition/
*  Plus it
This synergism of PL and DTX on colony formation can be explained on the basis of unique mechanism of action of PL and DTX. PL- ... Docetaxel (DTX) is an approved drug for the treatment of CRPC. However, development of DTX resistance and toxicity are the ... Poster Presentations - New Drugs, Therapeutic Targets, and Treatment Approaches. *. Abstract 3775: Mutated cancer cell-specific ... Despite the initial success of androgen ablation therapy, resistance to anti-androgen therapy manifests by progression to ...
  http://cancerres.aacrjournals.org/content/76/14_Supplement/2142
*  Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia - Full Text View -...
With its intrinsic resistance to many antimicrobial agents and rapid acquirement of resistance mechanism, resistance to ... which is often accompanied with resistance to multiple drugs, has emerged worldwide. The limited treatment choice included ... Combination of sulbactam and carbapenems has good synergism against A. baumannii with elevated minimal inhibitory concentration ... However, the emergence of resistance strains and discourage of monotherapy in severely ill patients make combination an ...
  https://clinicaltrials.gov/ct2/show/NCT01374256
*  Plus it
... and anticancer drug resistance (39). Because weak NM23-H1 expression is related to high Akt activation in ovarian carcinoma (40 ... Most importantly, the mechanisms driving the dynamic loss of NM23-H1 protein and the subsequent local tumor invasion at the ... Of note, MT1-MMP is predominantly expressed with nuclear β-catenin at the invasive front of colon carcinomas (44). Synergism ... instead inducing cellular resistance to chemotherapeutic drugs in vitro. Analysis of NM23-H1 expression in clinical specimens ...
  http://cancerres.aacrjournals.org/content/70/19/7710